Clinical implications of SLC26A7 in thyroid carcinoma: An observational study from TCGA and GEO

Abstract Thyroid carcinoma (THCA) is a common malignant endocrine tumor. Previously, we found that the expression of solute carrier family 26 member 7 (SLC26A7) in the thyroid gland is higher than that in other tissues. This study focused on the clinical importance of SLC26A7 in the diagnosis and prognosis of THCAs. SLC26A7 expression in THCA was analyzed using datasets from The Cancer Genome Atlas and Gene Expression Omnibus databases. The diagnostic accuracy of SLC26A7 was assessed using a receiver operating